fda warning letter bpc-157 compounding pharmacy issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA to weigh easing limits
Description
Patients with gastrointestinal disorders such as Crohns disease, celiac disease, or those who have undergone gastrointestinal surgeries (including gastric bypass) often experience impaired B12 absorption
Neurol Clin 14(2):317335
Safety Profile and Regulatory Considerations for Research Use
Bells palsy
After completing a short online medical intake, a licensed clinician will determine if the formula is right for you
